With Topline Data Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from With Topline Data Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In With Topline Data Expected Today - Breaking & Trending Today

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update

Published: August 10, 2023

NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener

Source: marketscreener.com

Related Topics:

United StatesDavid PittsJoseph OlivetoProgram UpdatesCenters For DiseaseExchange CommissionUs Securities Exchange CommissionMilestone PharmaceuticalsCompany PhaseDrug AdministrationPrnewswire Milestone Pharmaceuticals IncMilestone Pharmaceuticals IncHeart RhythmNew Drug ApplicationChief Executive OfficerEtripamil Nasal SprayIntranasal Etripamil UsingRepeat Dose RegimenFeatured During Oral SessionMeeting Support PotentialConcept TrialWith Topline Data ExpectedFourth QuarterSupraventricular TachycardiaAtrial Fibrillation